Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (RBR-5kkspwk) titled 'Botulinum Toxin Injections for Men with Erectile Dysfunction' on Oct. 23.
Study Type: Intervention
Study Design:
a phase 3, randomized-controlled, double-blind, parallel, treatment
Primary Sponsor: Hospital Universitario Pedro Ernesto
Condition:
Erectile dysfunction due to organic cause
Intervention:
This is a prospective, randomized, controlled, two-arm, double-blind clinical trial. A total of 60 participants who meet the eligibility criteria will be randomly assigned to one of the intervention groups using a random number table. Both the investigators responsible for outcome assessment and the participants wil...